Review: taking Coumadin and Nasacort together


Summary

Drug interactions are reported among people who take Coumadin and Nasacort together. This review analyzes the effectiveness and drug interactions between Coumadin and Nasacort. It is created by eHealthMe based on reports of 990 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coumadin and Nasacort >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 73,237 users)

Nasacort

Nasacort has active ingredients of triamcinolone acetonide. It is often used in hypersensitivity. (latest outcomes from Nasacort 3,994 users)

On Jul, 27, 2016

990 people who take Coumadin, Nasacort are studied.


Number of reports submitted per year:

Coumadin and Nasacort drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Nasacort:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 100.0% - (3 of 3 people)
  • male: 100.0% - (3 of 3 people)
Nasacort:
  • female: 66.0% - (2 of 3 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (3 of 3 people)
  • 60+: 100.0% - (2 of 2 people)
Nasacort:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 50.0% - (1 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • international normalised ratio increased
  • anaemia
  • skin exfoliation
  • bronchospasm
  • cough
  • deep vein thrombosis
  • dry skin
  • intestinal obstruction
  • ovarian cancer recurrent
  • pulmonary embolism
1 - 6 months:
  • myocardial infarction
6 - 12 months:
  • adenoma benign
  • aortic valve sclerosis
  • atrial fibrillation
  • atrial flutter
  • bladder disorder
  • bradycardia
  • bronchitis
  • candidiasis
  • carotid artery disease
  • cough
1 - 2 years:
  • amaurosis fugax
  • blindness transient
  • blindness unilateral
  • rash
  • retroperitoneal haemorrhage
2 - 5 years:
  • contusion
  • emotional distress
  • international normalised ratio increased
  • cerebrovascular accident
  • diarrhoea
  • epistaxis
  • anal fissure
  • anxiety
  • bleeding time abnormal
  • dyspnoea
5 - 10 years:
  • rash
not specified:
  • pain
  • anxiety
  • injury
  • atrial fibrillation
  • cardiac failure congestive
  • hypertension
  • fatigue
  • dyspnoea
  • asthenia
  • anaemia

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • injury
  • hypertension
  • anhedonia
  • depression
  • fatigue
  • asthenia
  • atrial fibrillation
  • urinary tract infection
male:
  • cardiac failure congestive
  • atrial fibrillation
  • pain
  • dyspnoea
  • renal failure acute
  • anxiety
  • injury
  • nausea
  • pyrexia
  • deep vein thrombosis

Most common drug interactions by age *:

10-19:
  • anxiety
  • deep vein thrombosis
  • emotional distress
  • general physical health deterioration
  • injury
  • pain
  • pulmonary embolism
  • pulmonary infarction
20-29:
  • cardiac failure congestive
  • bronchitis
  • cholecystitis
  • influenza like illness
  • urinary tract infection
  • atrial fibrillation
  • intracardiac thrombus
  • sinusitis
  • tuberculin test positive
  • insomnia
30-39:
  • pain
  • injury
  • anxiety
  • anhedonia
  • gastrooesophageal reflux disease
  • asthenia
  • myalgia
  • fatigue
  • bone callus excessive
  • bruxism
40-49:
  • dyspnoea
  • pain
  • nausea
  • anxiety
  • asthenia
  • chest pain
  • dizziness
  • fatigue
  • headache
  • insomnia
50-59:
  • pain
  • cardiac failure congestive
  • hypertension
  • anhedonia
  • anxiety
  • deep vein thrombosis
  • injury
  • depression
  • arthralgia
  • neuropathy peripheral
60+:
  • atrial fibrillation
  • pain
  • anxiety
  • injury
  • osteoarthritis
  • hypertension
  • cardiac failure congestive
  • dyspnoea
  • anaemia
  • nausea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Nasacort?

Can you answer these questions?

More questions for: Coumadin, Nasacort

You may be interested in these reviews

More reviews for: Coumadin, Nasacort

On eHealthMe, Coumadin (warfarin sodium) is often used to treat atrial fibrillation/flutter. Nasacort (triamcinolone acetonide) is often used to treat hypersensitivity. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.